Long-Acting Cariprazine (Anxo Pharmaceutical)

N/A

Report date: 2026/03/23 20:03:44

Base Information

Drug NameLong-Acting Cariprazine (Anxo Pharmaceutical)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor antagonistsDopamine D2 receptor partial agonistsDopamine D3 receptor partial agonists +[6] 
TargetsSerotonin 2a (5-HT2a) receptorDopamine D2 receptorDopamine D3 receptor +[6] 
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAnxo Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAnxo Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsSchizophrenia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A